Global Respiratory Care Devices Market Is Expected to Reach USD 41.20 Billion by 2027 : Fior Markets
April 10, 2020 05:15 ET
|
Fior Markets
Newark, NJ, April 10, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global respiratory care devices market is expected to grow from USD 23.03 billion in 2019 and to reach...
Respiratory Care Devices Market To Reach USD 37.04 Billion By 2027 | Reports and Data
April 02, 2020 15:00 ET
|
Reports and Data
New York, April 02, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global Respiratory Care Devices Market valued at USD 18.41 Billion in 2019 and is expected to...
Durable Medical Equipment Market worth over USD 275 Bn by 2026: Global Market Insights, Inc.
March 05, 2020 04:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, March 05, 2020 (GLOBE NEWSWIRE) -- Global Market Insights, Inc. has recently added a new report on durable medical equipment market which estimates the global market...
Endonovo Therapeutics Files 8K With SEC Regarding SofPulse®
March 02, 2020 07:30 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, March 02, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced it has filed an 8K with the Securities and Exchange...
Endonovo Therapeutics Introduces Support of SofPulse® With A New Ancillary Multi-Use Patient Brace From Protex
February 24, 2020 13:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced the production and introduction of an ancillary multi-use...
Global Sleep Apnea Devices Market is Expected to Reach USD 10.6 Billion by 2025 : Fior Markets
February 21, 2020 11:00 ET
|
Fior Markets
Newark, NJ, Feb. 21, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global sleep apnea devices market is expected to grow from USD 5.2 Billion in 2017 to USD 10.6 Billion...
Endonovo Therapeutics Announces Issuance of Broad Patent Covering Electromagnetic Treatment of Multiple Sclerosis
January 14, 2020 09:00 ET
|
Endonovo Therapeutics, Inc.
● This furthers Endonovo’s strategy to commercialize and protect its Electroceutical(s)® Los Angeles, CA, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or...
Endonovo Therapeutics Provides SofPulse® To All NFL Teams
December 23, 2019 08:30 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today the delivery of SofPulse® evaluation units to all...
Endonovo Therapeutics Announces Reverse Stock Split
October 31, 2019 12:43 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced that it had filed a preliminary information statement...
Endonovo Therapeutics Appoints Dr. William Li as Strategic Advisor to the CEO
September 30, 2019 09:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announces it has appointed Dr. William Li as Strategic Advisor to...